Apoptotic Extracellular Vesicles Ameliorate Multiple Myeloma by Restoring Fas-Mediated Apoptosis
Author(s) -
Juan Wang,
Zeyuan Cao,
Panpan Wang,
Xiao Zhang,
Jianxia Tang,
Yifan He,
Zhiqing Huang,
Xueli Mao,
Songtao Shi,
Xiaoxing Kou
Publication year - 2021
Publication title -
acs nano
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 5.554
H-Index - 382
eISSN - 1936-086X
pISSN - 1936-0851
DOI - 10.1021/acsnano.1c03517
Subject(s) - apoptosis , fas ligand , microbiology and biotechnology , extracellular , cell , cytoplasm , intracellular , programmed cell death , biology , mesenchymal stem cell , uvb induced apoptosis , fas receptor , cancer cell , chemistry , caspase , cancer , biochemistry , genetics
Apoptosis is critical for maintaining bodily homeostasis and produces a large number of apoptotic extracellular vesicles (apoEVs). Several types of cancer cells display reduced expression of Fas on the cell surface and are thus capable of escaping Fas ligand-induced apoptosis. However, it is unknown whether normal cell-derived apoEVs can regulate tumor growth. In this study, we show that apoEVs can induce multiple myeloma (MM) cell apoptosis and inhibit MM cell growth. Systemic infusion of mesenchymal stem cell (MSC)-derived apoEVs significantly prolongs the lifespan of MM mice. Mechanistically, apoEVs directly contact MM cells to facilitate Fas trafficking from the cytoplasm to the cell membrane by evoking Ca 2+ influx and elevation of cytosolic Ca 2+ . Subsequently, apoEVs use their Fas ligand to activate the Fas pathway in MM cells, leading to the initiation of apoptosis. This study identifies the role of apoEVs in inducing MM apoptosis and suggests a potential for apoEVs to treat MM.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom